"Is this the end of UFH? We continue to have more and more evidence suggesting better and safer outcomes with low-molecular-weight heparin, and we as interventionalists should pay attention to this." ...
LONDON, June 5 (Reuters) - Doctors in Europe can continue to use Sanofi-Aventis SA's heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European ...
LONDON, March 5 (Reuters) - Pfizer and Bristol-Myers Squibb's anti-clotting pill apixaban proved better than standard treatment Lovenox in a late-stage knee surgery trial, boosting prospects for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results